Back to Search
Start Over
Evaluation of VeriStrat, a serum proteomic test, in the randomized, open-label, Phase 3 LUX-Lung 8 trial of afatinib versus erlotinib for the second-line treatment of advanced squamous cell carcinoma of the lung
- Source :
- Annals of Oncology. 27:vi428
- Publication Year :
- 2016
- Publisher :
- Elsevier BV, 2016.
- Subjects :
- Oncology
medicine.medical_specialty
Second line treatment
Squamous-cell carcinoma of the lung
Lung
business.industry
Afatinib
Hematology
030204 cardiovascular system & hematology
03 medical and health sciences
0302 clinical medicine
medicine.anatomical_structure
030220 oncology & carcinogenesis
Internal medicine
Medicine
Erlotinib
Open label
Veristrat
business
medicine.drug
Subjects
Details
- ISSN :
- 09237534
- Volume :
- 27
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology
- Accession number :
- edsair.doi...........daa49e7f5c2f7cb1d238f8545d3caf98
- Full Text :
- https://doi.org/10.1093/annonc/mdw383.38